EUROBIO-SCIENTIFIC (ALERS.PA) Stock Fundamental Analysis
EPA:ALERS - FR0013240934 - Common Stock
25.25 EUR
-0.25 (-0.98%)
ALERS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 74 industry peers in the Biotechnology industry. ALERS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALERS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ALERS was profitable.
ALERS had a positive operating cash flow in the past year.
ALERS had positive earnings in each of the past 5 years.
Each year in the past 5 years ALERS had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 1.55%, ALERS is doing good in the industry, outperforming 74.32% of the companies in the same industry.
With a decent Return On Equity value of 2.24%, ALERS is doing good in the industry, outperforming 77.03% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.25%, ALERS is doing good in the industry, outperforming 79.73% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALERS is significantly below the industry average of 12.87%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 2.24% | ||
| ROIC | 4.25% |
ROA(3y)3.54%
ROA(5y)16.42%
ROE(3y)6.48%
ROE(5y)25.15%
ROIC(3y)5.13%
ROIC(5y)17.09%
1.3 Margins
ALERS has a Profit Margin of 2.59%. This is in the better half of the industry: ALERS outperforms 77.03% of its industry peers.
ALERS's Profit Margin has declined in the last couple of years.
ALERS has a better Operating Margin (8.81%) than 81.08% of its industry peers.
ALERS's Operating Margin has improved in the last couple of years.
ALERS has a Gross Margin of 46.49%. This is comparable to the rest of the industry: ALERS outperforms 54.05% of its industry peers.
In the last couple of years the Gross Margin of ALERS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.81% | ||
| PM (TTM) | 2.59% | ||
| GM | 46.49% |
OM growth 3Y-38.55%
OM growth 5Y55.68%
PM growth 3Y-57.11%
PM growth 5Y-13.49%
GM growth 3Y-5.65%
GM growth 5Y7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALERS is destroying value.
The number of shares outstanding for ALERS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALERS has less shares outstanding
ALERS has a better debt/assets ratio than last year.
2.2 Solvency
ALERS has an Altman-Z score of 3.82. This indicates that ALERS is financially healthy and has little risk of bankruptcy at the moment.
ALERS's Altman-Z score of 3.82 is amongst the best of the industry. ALERS outperforms 82.43% of its industry peers.
ALERS has a debt to FCF ratio of 2.53. This is a good value and a sign of high solvency as ALERS would need 2.53 years to pay back of all of its debts.
ALERS's Debt to FCF ratio of 2.53 is amongst the best of the industry. ALERS outperforms 89.19% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ALERS is not too dependend on debt financing.
ALERS's Debt to Equity ratio of 0.17 is fine compared to the rest of the industry. ALERS outperforms 64.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 2.53 | ||
| Altman-Z | 3.82 |
ROIC/WACC0.61
WACC6.94%
2.3 Liquidity
ALERS has a Current Ratio of 2.03. This indicates that ALERS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.03, ALERS is in line with its industry, outperforming 50.00% of the companies in the same industry.
ALERS has a Quick Ratio of 1.42. This is a normal value and indicates that ALERS is financially healthy and should not expect problems in meeting its short term obligations.
ALERS's Quick ratio of 1.42 is on the low side compared to the rest of the industry. ALERS is outperformed by 62.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The earnings per share for ALERS have decreased by -7.60% in the last year.
ALERS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.82% yearly.
The Revenue has grown by 18.89% in the past year. This is quite good.
Measured over the past years, ALERS shows a very strong growth in Revenue. The Revenue has been growing by 21.21% on average per year.
EPS 1Y (TTM)-7.6%
EPS 3Y-58.79%
EPS 5Y6.82%
EPS Q2Q%-100.04%
Revenue 1Y (TTM)18.89%
Revenue growth 3Y-5.77%
Revenue growth 5Y21.21%
Sales Q2Q%14.74%
3.2 Future
The Earnings Per Share is expected to grow by 34.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.25% on average over the next years. This is quite good.
EPS Next Y31.82%
EPS Next 2Y34.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.49%
Revenue Next 2Y9.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 63.13, ALERS can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ALERS is valued a bit cheaper than 79.73% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. ALERS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 21.13 indicates a rather expensive valuation of ALERS.
78.38% of the companies in the same industry are more expensive than ALERS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALERS to the average of the S&P500 Index (22.63), we can say ALERS is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.13 | ||
| Fwd PE | 21.13 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALERS indicates a rather cheap valuation: ALERS is cheaper than 89.19% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALERS indicates a rather cheap valuation: ALERS is cheaper than 85.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.25 | ||
| EV/EBITDA | 8.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALERS does not grow enough to justify the current Price/Earnings ratio.
ALERS has a very decent profitability rating, which may justify a higher PE ratio.
ALERS's earnings are expected to grow with 34.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.98
PEG (5Y)9.26
EPS Next 2Y34.84%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ALERS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALERS (9/4/2025, 7:00:00 PM)
25.25
-0.25 (-0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners4.28%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap258.81M
Analysts84.44
Price Target30.6 (21.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.13 | ||
| Fwd PE | 21.13 | ||
| P/S | 1.67 | ||
| P/FCF | 19.25 | ||
| P/OCF | 15.49 | ||
| P/B | 1.45 | ||
| P/tB | 10.28 | ||
| EV/EBITDA | 8.81 |
EPS(TTM)0.4
EY1.58%
EPS(NY)1.19
Fwd EY4.73%
FCF(TTM)1.31
FCFY5.2%
OCF(TTM)1.63
OCFY6.45%
SpS15.08
BVpS17.43
TBVpS2.46
PEG (NY)1.98
PEG (5Y)9.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 2.24% | ||
| ROCE | 6.39% | ||
| ROIC | 4.25% | ||
| ROICexc | 4.76% | ||
| ROICexgc | 24.83% | ||
| OM | 8.81% | ||
| PM (TTM) | 2.59% | ||
| GM | 46.49% | ||
| FCFM | 8.7% |
ROA(3y)3.54%
ROA(5y)16.42%
ROE(3y)6.48%
ROE(5y)25.15%
ROIC(3y)5.13%
ROIC(5y)17.09%
ROICexc(3y)7.07%
ROICexc(5y)35.47%
ROICexgc(3y)44.03%
ROICexgc(5y)78.19%
ROCE(3y)7.73%
ROCE(5y)25.78%
ROICexcg growth 3Y-35.35%
ROICexcg growth 5Y49.79%
ROICexc growth 3Y-58%
ROICexc growth 5Y39.27%
OM growth 3Y-38.55%
OM growth 5Y55.68%
PM growth 3Y-57.11%
PM growth 5Y-13.49%
GM growth 3Y-5.65%
GM growth 5Y7%
F-Score7
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 2.53 | ||
| Debt/EBITDA | 1.02 | ||
| Cap/Depr | 19.09% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 54.46% | ||
| Profit Quality | 336.34% | ||
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.82 |
F-Score7
WACC6.94%
ROIC/WACC0.61
Cap/Depr(3y)26.09%
Cap/Depr(5y)27.29%
Cap/Sales(3y)2.36%
Cap/Sales(5y)1.86%
Profit Quality(3y)322.49%
Profit Quality(5y)228.98%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.6%
EPS 3Y-58.79%
EPS 5Y6.82%
EPS Q2Q%-100.04%
EPS Next Y31.82%
EPS Next 2Y34.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.89%
Revenue growth 3Y-5.77%
Revenue growth 5Y21.21%
Sales Q2Q%14.74%
Revenue Next Year9.49%
Revenue Next 2Y9.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.36%
EBIT growth 3Y-42.09%
EBIT growth 5Y88.7%
EBIT Next Year35.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.8%
FCF growth 3Y-40.57%
FCF growth 5Y31.67%
OCF growth 1Y-37.6%
OCF growth 3Y-36.72%
OCF growth 5Y27.33%